Xi'an International Medical Center Hospital Affiliated TO Northwest University
Xi'an, Shaanxi, 710100, China
Location status: Recruiting
Location contact
Jinzhou Zhang, Doctorate
CONTACT
Zhen Wang, Doctorate
CONTACT
NCT Number: NCT06857838
Myocardial Bridge Bypass Graft surgery is introduced to relieve the unmedical symptoms of patients with long-segment or deep myocardial bridge, clinical outcomes will be collected to verify the effectiveness of the surgery.
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Not applicable
Xi'an, Shaanxi, 710100, China
Location status: Recruiting
Jinzhou Zhang, Doctorate
CONTACT
Zhen Wang, Doctorate
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The patients with deep(depth>2mm) and long-segement(length>25mm) of myocardialbridge receiving myocardialbridge bypass graft surgery(MBBG),fulfilling the following criteria: 1.presenting with pectoris angina that cannot be effectively relieved by maximum guideline-directed drug therapy; 2. No atherosclerotic plaque or merely mild atherosclerotic stenosis is detected at the proximal or entry of the myocardialbridge confirmed by coronory artery angiography.
The patients with deep(depth>2mm) and long-segement(length>25mm) of myocardialbridge receiving myocardialbridge bypass graft surgery(MBBG),fulfilling the following criteria: 1.presenting with pectoris angina that cannot be effectively relieved by maximum guideline-directed drug therapy; 2. The moderate-to-severe atherosclerotic stenosis is detected at the proximal or entry of the myocardialbridge confirmed by coronory artery angiography.
The patients with superficial type(depth<2mm) and short-segement(length<25mm) of myocardial bridge will be allocated to receive myocardialbridge "unroof" surgery,when fulfilling the following criteria: 1.presenting with pectoris angina that cannot be effectively relieved by maximum guideline-directed drug therapy; 2. The MB was superficial and short confirmed by coronory artery CT angiography.
Time frame: Up to 240 months
Time frame: Up to 180 months
Contact information is provided by the study sponsor or research team.
Jinzhou Zhang, Doctorate
CONTACT
Zhen Wang, Doctorate
CONTACT
Xi'an International Medical Center Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04869150
Cardiovascular Abnormalities, Cardiovascular Diseases
Izmir, Turkey (Türkiye)
View Trial DetailsNCT04082546
Angina Pectoris, Cardiovascular Diseases
Ancona, Italy
View Trial DetailsNCT06424834
Angina Pectoris, Angina Pectoris, Variant
Palo Alto, California, United States
View Trial DetailsNCT05238103
Arterial Occlusive Diseases, Arteriosclerosis
Baltimore, Maryland, United States
View Trial Details